Repurposing Mirtazapine in Rett Syndrome

Clinical trial NCT07430046 · RECRUITING

Trial details

NCT number: NCT07430046
Sponsor: University of Trieste
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

RETT Syndrome With Proven MECP2 Mutation

Start date: 2025-07-09
Primary completion: 2026-06-30
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.